News
-
-
-
COMMUNIQUÉ DE PRESSE
Biotest obtains approval for new human fibrinogen Prufibry® in Germany
Biotest AG obtains approval in Germany for new human fibrinogen Prufibry®, expanding intensive care and coagulation factor portfolio with a life-saving therapy for congenital and acquired fibrinogen deficiency -
-
-
-
-
-
-